The drug can triple life expectancy for people with the rare and aggressive form of cancer.
Trending
- Outlining Exercise as a “Biologically Interventional Therapy” for Cancer
- ‘Dance class helped me find a bit of myself I’d lost to cancer’
- Scientists say house cats could help unlock new cancer treatments for humans
- How boy who lost life to rare cancer is helping other children
- Signals from the bone marrow B cell niches shape pre-leukemic fate in a murine model of B cell acute lymphoblastic leukemia
- FGFR3 oncogenic activation drives oxidative metabolic reprogramming in bladder cancer: a systems metabolomics approach
- 95 monarchE: Subgroup Analysis of Adjuvant Abemaciclib + Endocrine Therapy for HR+/HER2−, High-Risk, Early Breast Cancer by Nodal Status
- 96 Efficacy and Safety of Abemaciclib in Younger Patients With Early Breast Cancer in the monarchE Trial

